NDC 45963-615
Topotecan hydrochloride
Topotecan Hydrochloride
Topotecan hydrochloride is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Topotecan Hydrochloride.
| Product ID | 45963-615_0edbf531-9ae9-4f9d-a606-f8f56768ce9d |
| NDC | 45963-615 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Topotecan hydrochloride |
| Generic Name | Topotecan Hydrochloride |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2015-01-05 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA090620 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | TOPOTECAN HYDROCHLORIDE |
| Active Ingredient Strength | 4 mg/4mL |
| Pharm Classes | Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |